Mitral Valve

The heart's mitral valve is the site of the most surgical valve repairs and valve replacements. After the resounding success of transcatheter aortic valve replacement (TAVR), which now makes up more than 50% of aortic valve replacements, there is wide expectation transcatheter mitral replacements will follow in the next few year. Currently, the most common transcatheter mitral procedure is transcatheter edge-to-edge (TEER) , using the MitraClip or Pascal clip devices. These devices are also being used for transcatheter tricuspid valve repair (TTVR). Other transcatheter mitral repair systems are in trials for minimally invasive annuloplasty and chordae tendineae repair. 

Old doctor

TEER associated with ‘important and significant’ reductions in hospitalization rates

Considering the study's high-risk patient population, researchers were especially impressed by these one-year outcomes.

October 22, 2021
surgery.jpg

CUTTING-EDGE findings shine new light on mitral valve surgery after failed TEER

Overall, mitral valve surgery after TEER was associated with a 30-day mortality rate of 16.6% and one-year mortality rate of 31.3%.

October 8, 2021

TEER benefits all HF patients with SMR, but men see more long-term benefits

The study's authors examined data from men and women who underwent TEER with the MitraClip device in addition to guideline-directed medical therapy. 

September 22, 2021

Valve-in-valve TMVR an effective option for patients with mitral prosthesis dysfunction

Adjusted mortality and perioperative complications were both lower among patients undergoing ViV TMVR.

September 8, 2021

Survival rates similar when treating secondary MR with TEER or surgery

Surgical mitral valve repair, however, was also associated with multiple benefits.

September 7, 2021
A doctor speaking with a patient

TMVR outcomes suffer when patients have heart failure and diabetes—but benefits remain

Overall, the authors emphasized, TMVR helped heart failure patients with and without diabetes.

August 9, 2021
Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings

Next-day discharge after TMVR is on the rise

By 2018, nearly half of all TMVR patients were going home the very next day. Outcomes for these patients have been consistently positive. 

August 9, 2021

TEER shows potential to boost outcomes for cardiogenic shock patients

Cardiogenic shock has been linked to a heightened risk of morbidity and mortality. TEER, it seems, may be able to help provide patients with some relief. 

July 29, 2021

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup